Oruka Therapeutics, Inc. Shares Outstanding (Cover Page)
Oruka Therapeutics, Inc. (ORKA) had Shares Outstanding (Cover Page) of 66.21 million shares as of 2026-07-31, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-07-31: Entity Common Stock, Shares Outstanding 66.21M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 60.31M shares.
- 2026-02-28: Entity Common Stock, Shares Outstanding 49.54M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 48.41M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 66.21M shares 10-Q · filed 2026-08-10 |
| 2026-04-30 | 60.31M shares 10-Q · filed 2026-05-13 |
| 2026-02-28 | 49.54M shares 10-K · filed 2026-03-12 |
| 2025-10-31 | 48.41M shares 10-Q · filed 2025-11-12 |
| 2025-07-31 | 37.45M shares 10-Q · filed 2025-08-11 |
| 2025-04-30 | 37.44M shares 10-Q · filed 2025-05-14 |
| 2025-02-28 | 37.44M shares 10-K · filed 2025-03-06 |
| 2024-10-31 | 35.00M shares 10-Q · filed 2024-11-13 |
| 2024-07-31 | 14.51M shares 10-Q · filed 2024-08-01 |
| 2024-04-24 | 14.51M shares 10-Q · filed 2024-04-25 |
| 2024-01-31 | 14.50M shares 10-K · filed 2024-02-01 |
| 2023-10-17 | 14.41M shares 10-Q · filed 2023-10-18 |
| 2023-07-20 | 14.41M shares 10-Q · filed 2023-07-21 |
| 2023-04-24 | 14.41M shares 10-Q · filed 2023-04-24 |
| 2023-02-23 | 14.41M shares 10-K · filed 2023-02-24 |
| 2022-10-27 | 14.41M shares 10-Q · filed 2022-10-28 |
| 2022-08-01 | 14.41M shares 10-Q · filed 2022-08-02 |
| 2022-04-29 | 14.41M shares 10-Q · filed 2022-05-02 |
| 2022-03-11 | 14.41M shares 10-K · filed 2022-03-14 |
| 2021-11-01 | 14.41M shares 10-Q · filed 2021-11-02 |
| 2021-08-03 | 14.41M shares 10-Q · filed 2021-08-04 |
| 2021-05-10 | 14.41M shares 10-Q · filed 2021-05-11 |
| 2021-03-16 | 14.41M shares 10-K · filed 2021-03-18 |
| 2020-10-30 | 9.32M shares 10-Q · filed 2020-11-02 |
| 2020-07-31 | 5.91M shares 10-Q · filed 2020-08-05 |
| 2020-05-05 | 1.59M shares 10-Q · filed 2020-05-06 |
| 2020-02-13 | 1.59M shares 10-K · filed 2020-02-18 |
| 2019-11-01 | 1.59M shares 10-Q · filed 2019-11-06 |
| 2019-07-31 | 1.46M shares 10-Q · filed 2019-08-01 |
| 2019-05-06 | 1.10M shares 10-Q · filed 2019-05-08 |
| 2019-02-22 | 18.36M shares 10-K · filed 2019-02-27 |
| 2018-11-12 | 13.92M shares 10-Q · filed 2018-11-14 |
| 2018-08-07 | 13.92M shares 10-Q · filed 2018-08-09 |
| 2018-05-04 | 13.92M shares 10-Q · filed 2018-05-08 |
| 2018-03-19 | 13.91M shares 10-K · filed 2018-03-22 |
| 2017-11-07 | 11.75M shares 10-Q · filed 2017-11-09 |
| 2017-07-31 | 11.75M shares 10-Q · filed 2017-08-03 |
| 2017-05-11 | 9.24M shares 10-Q · filed 2017-05-15 |
| 2017-03-17 | 9.13M shares 10-K · filed 2017-03-21 |
| 2016-11-10 | 9.08M shares 10-Q · filed 2016-11-14 |
| 2016-08-05 | 9.07M shares 10-Q · filed 2016-08-09 |
| 2016-05-09 | 9.07M shares 10-Q · filed 2016-05-11 |
| 2016-03-15 | 9.06M shares 10-K · filed 2016-03-17 |
| 2015-11-10 | 9.05M shares 10-Q · filed 2015-11-12 |
| 2015-08-07 | 63.22M shares 10-Q · filed 2015-08-11 |
| 2015-05-11 | 21.20M shares 10-Q · filed 2015-05-12 |
| 2015-03-17 | 21.20M shares 10-K · filed 2015-03-19 |
| 2014-11-10 | 21.15M shares 10-Q · filed 2014-11-12 |
| 2014-08-12 | 21.01M shares 10-Q · filed 2014-08-13 |
| 2014-05-09 | 21.01M shares 10-Q · filed 2014-05-13 |
| 2014-03-17 | 20.98M shares 10-K · filed 2014-03-20 |
| 2013-11-08 | 15.68M shares 10-Q · filed 2013-11-13 |
| 2013-08-09 | 10.95M shares 10-Q · filed 2013-08-13 |
| 2013-05-10 | 3.19M shares 10-Q · filed 2013-05-13 |
| 2013-03-18 | 3.19M shares 10-K · filed 2013-03-21 |
| 2012-11-09 | 15.44M shares 10-Q · filed 2012-11-13 |
| 2012-08-10 | 14.62M shares 10-Q · filed 2012-08-13 |
| 2012-05-11 | 12.18M shares 10-Q · filed 2012-05-14 |
| 2012-03-23 | 12.18M shares 10-K · filed 2012-03-27 |
| 2011-11-09 | 10.52M shares 10-Q · filed 2011-11-14 |
| 2011-08-11 | 10.52M shares 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |